{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Rebeccamycin",
  "nciThesaurus": {
    "casRegistry": "93908-02-2",
    "chebiId": "CHEBI:135511",
    "chemicalFormula": "",
    "definition": "An indolocarbazole glycoside antineoplastic antibiotic isolated from the bacterium Saccharothrix aerocolonigenes.  Rebeccamycin intercalates into DNA and stabilizes the DNA-topoisomerase I complex, thereby interfering with the topoisomerase I-catalyzed DNA breakage-reunion reaction and initiating DNA cleavage and apoptosis.",
    "fdaUniiCode": "Y96MQM21V9",
    "identifier": "C1213",
    "preferredName": "Rebeccamycin",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C1904",
      "C582"
    ],
    "synonyms": [
      "5H-Indolo[2, 3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione, 1,11-dichloro-12, 13-dihydro-12-(4-O-methyl-.beta.-D-glucopyranosyl)-",
      "5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione,1,11-dichloro-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)",
      "BRN 4732638",
      "REBECCAMYCIN",
      "Rebeccamycin",
      "rebeccamycin"
    ]
  }
}